Silent
Missense
Nonsense
Frequency of SNVs in pancancer level
| Cancer | Full Name | Mutation | Mutation Type | Sample Number |
|---|---|---|---|---|
| COAD | Colon adenocarcinoma | E239G | Missense | 2 |
| BLCA | Bladder urothelial carcinoma | D282H | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | H35Q | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | N47H | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | R206H | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | V19M | Missense | 1 |
| BRCA | Breast invasive carcinoma | E224D | Missense | 1 |
| BRCA | Breast invasive carcinoma | R190Q | Missense | 1 |
| BRCA | Breast invasive carcinoma | T300T | Silent | 1 |
| CESC | Cervical and endocervical cancers | E224K | Missense | 1 |
| COAD | Colon adenocarcinoma | G187V | Missense | 1 |
| COAD | Colon adenocarcinoma | L324I | Missense | 1 |
| COAD | Colon adenocarcinoma | P340L | Missense | 1 |
| COAD | Colon adenocarcinoma | P96P | Silent | 1 |
| COAD | Colon adenocarcinoma | P97P | Silent | 1 |
| COAD | Colon adenocarcinoma | R23H | Missense | 1 |
| ESCA | Esophageal carcinoma | P327P | Silent | 1 |
| HNSC | Head and Neck squamous cell carcinoma | A334T | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | I92I | Silent | 1 |
| HNSC | Head and Neck squamous cell carcinoma | L250Q | Missense | 1 |
| KIRC | Kidney renal clear cell carcinoma | E13Q | Missense | 1 |
| KIRP | Kidney renal papillary cell carcinoma | L80L | Silent | 1 |
| KIRP | Kidney renal papillary cell carcinoma | Y79S | Missense | 1 |
| LIHC | Liver hepatocellular carcinoma | R290H | Missense | 1 |
| LUAD | Lung adenocarcinoma | I219M | Missense | 1 |
| LUAD | Lung adenocarcinoma | I311V | Missense | 1 |
| LUAD | Lung adenocarcinoma | L165L | Silent | 1 |
| LUAD | Lung adenocarcinoma | L319V | Missense | 1 |
| LUAD | Lung adenocarcinoma | R174S | Missense | 1 |
| OV | Ovarian serous cystadenocarcinoma | E239V | Missense | 1 |
| OV | Ovarian serous cystadenocarcinoma | P96P | Silent | 1 |
| PRAD | Prostate adenocarcinoma | G149G | Silent | 1 |
| READ | Rectum adenocarcinoma | A156A | Silent | 1 |
| SKCM | Skin Cutaneous Melanoma | E68E | Silent | 1 |
| SKCM | Skin Cutaneous Melanoma | F192L | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | L297F | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | P113L | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | P36L | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | V169G | Missense | 1 |
| STAD | Stomach adenocarcinoma | F104L | Missense | 1 |
| STAD | Stomach adenocarcinoma | G149G | Silent | 1 |
| STAD | Stomach adenocarcinoma | L101I | Missense | 1 |
| STAD | Stomach adenocarcinoma | P330S | Missense | 1 |
| STAD | Stomach adenocarcinoma | R115W | Missense | 1 |
| STAD | Stomach adenocarcinoma | R197H | Missense | 1 |
| STAD | Stomach adenocarcinoma | R307H | Missense | 1 |
| STAD | Stomach adenocarcinoma | R310H | Missense | 1 |
| STAD | Stomach adenocarcinoma | R64W | Missense | 1 |
| STAD | Stomach adenocarcinoma | R78H | Missense | 1 |
| TGCT | Testicular Germ Cell Tumors | L263L | Silent | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | D261N | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | L180I | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | P22P | Silent | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | R15H | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | R213H | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | R78H | Missense | 1 |
Mutational percentage of Silent, Missense and Nonsense for various cancers
Summary of mutation in pancancer level
| Cancer | Full Name | # Sample | % Silent | % Missense | % Nonsense |
|---|---|---|---|---|---|
| BLCA | Bladder urothelial carcinoma | 394 | 0 | 11.6 | 0 |
| BRCA | Breast invasive carcinoma | 976 | 7.1 | 4.7 | 0 |
| CESC | Cervical and endocervical cancers | 194 | 0 | 2.3 | 0 |
| COAD | Colon adenocarcinoma | 367 | 14.3 | 14 | 0 |
| ESCA | Esophageal carcinoma | 185 | 7.1 | 0 | 0 |
| GBM | Glioblastoma multiforme | 283 | 0 | 0 | 0 |
| HNSC | Head and Neck squamous cell carcinoma | 511 | 7.1 | 4.7 | 0 |
| KIRC | Kidney renal clear cell carcinoma | 476 | 0 | 2.3 | 0 |
| KIRP | Kidney renal papillary cell carcinoma | 282 | 7.1 | 2.3 | 0 |
| LAML | Acute Myeloid Leukemia | 192 | 0 | 0 | 0 |
| LGG | Brain Lower Grade Glioma | 516 | 0 | 0 | 0 |
| LIHC | Liver hepatocellular carcinoma | 373 | 0 | 2.3 | 0 |
| LUAD | Lung adenocarcinoma | 533 | 7.1 | 9.3 | 0 |
| LUSC | Lung squamous cell carcinoma | 177 | 0 | 0 | 0 |
| OV | Ovarian serous cystadenocarcinoma | 465 | 7.1 | 2.3 | 0 |
| PAAD | Pancreatic adenocarcinoma | 126 | 0 | 0 | 0 |
| PCPG | Pheochromocytoma and Paraganglioma | 179 | 0 | 0 | 0 |
| PRAD | Prostate adenocarcinoma | 498 | 7.1 | 0 | 0 |
| READ | Rectum adenocarcinoma | 122 | 7.1 | 0 | 0 |
| SARC | Sarcoma | 247 | 0 | 0 | 0 |
| SKCM | Skin Cutaneous Melanoma | 290 | 7.1 | 11.6 | 0 |
| STAD | Stomach adenocarcinoma | 393 | 7.1 | 20.9 | 0 |
| TGCT | Testicular Germ Cell Tumors | 147 | 7.1 | 0 | 0 |
| THCA | Thyroid carcinoma | 495 | 0 | 0 | 0 |
| THYM | Thymoma | 119 | 0 | 0 | 0 |
| UCEC | Uterine Corpus Endometrial Carcinoma | 248 | 7.1 | 11.6 | 0 |